Caricamento...

Lapatinib – Member of a New Generation of ErbB-Targeting Drugs

SUMMARY: Women with advanced or metastatic ErbB2 (HER2)-positive breast cancer have limited therapeutic options once their disease has progressed on trastuzumab-based standard initial chemotherapy regimens. Therefore, there has been a clear need for alternative treatments in this advanced setting. T...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Untch, Michael, Lück, Hans-Joachim
Natura: Artigo
Lingua:Inglês
Pubblicazione: S. Karger GmbH 2010
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2931094/
https://ncbi.nlm.nih.gov/pubmed/20847830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000285750
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !